TREM2/DAP12 complex promotes proliferation and invasion of glioma cells via the PI3K-AKT signaling pathway
Folia Neuropathologica · 2025
DOI: 10.5114/fn.2025.156003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Neuropathologica, 2025. Verfasst von Zhitong Deng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First People's Hospital of Huzhou (First Affiliated Hospital of Huzhou University), Huzhou, Zhejiang 313000, China. Hauptthemen laut MEDLINE: Membrane Glycoproteins, Receptors, Immunologic, Glioma, Brain Neoplasms.
Abstract (Originalsprache)
INTRODUCTION: Triggering receptor expressed on myeloid cells 2 (TREM2), part of the immunoglobulin superfamily, is implicated in various malignancies. However, its role in glioma formation remains unclear. Our study uncovered a potential mechanism involving TREM2. MATERIAL AND METHODS: The Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlas (CGGA) datasets were utilized to assess the expression levels of TREM2 and DNAX-activating protein of 12 kDa (DAP12), explore their relationship, and evaluate their impact on patient prognosis. Western blotting was used to measure TREM2 expression in different glioma grades. Co-immunoprecipitation (Co-IP) was used to examine TREM2 and DAP12 interaction. Cell proliferation, invasion, and apoptosis were assessed via the cell proliferation test, cell invasion assay, and flow cytometry. An intracranial xenograft model was created by injecting tumor cells into nude mice. Mice injected with si-DAP12-transfected or non-transfected glioma cells were treated with 740Y-P, followed by survival analysis and immunohistochemistry. RESULTS: TREM2 and DAP12 were overexpressed in gliomas, with high levels associated with lower overall survival (p < 0.05 and p < 0.01). There was a strong positive correlation between TREM2 and DAP12 expression (p < 0.0001). TREM2 positively regulated DAP12, forming a complex that influenced glioma cell proliferation, apoptosis, and invasion (p < 0.05, p < 0.01, and p < 0.001). DAP12 knockdown significantly inhibited proliferation and invasion while promoting apoptosis of glioma cells, linked to the PI3K/AKT signaling pathway (p < 0.05 and p < 0.01). 740Y-P treatment counteracted the effects of DAP12 knockdown (p < 0.05, p < 0.01, p < 0.001, and p < 0.0001). In vivo, DAP12 knockdown inhibited glioma tumorigenicity (p < 0.001). CONCLUSIONS: TREM2 positively regulates DAP12 and forms a complex that impacts glioma development via the PI3K/AKT pathway. Targeting the TREM2/DAP12 complex presents a potential therapeutic approach for gliomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The First People's Hospital of Huzhou (First Affiliated Hospital of Huzhou University), Huzhou, Zhejiang 313000, China.
- Department of Neurosurgery, The First People's Hospital of Huzhou (First Affiliated Hospital of Huzhou University), Huzhou, Zhejiang 313000, China. zz2hdo@163.com.
Zitieren
APA
Deng, Z., Zhong, X., Cai, Y., Yang, J., Wang, Y., Fei, Z., Gu, H., Yang, T., & Zhao, Z. (2025). TREM2/DAP12 complex promotes proliferation and invasion of glioma cells via the PI3K-AKT signaling pathway. Folia Neuropathologica. https://doi.org/10.5114/fn.2025.156003
Vancouver
Deng Z, Zhong X, Cai Y, Yang J, Wang Y, Fei Z, et al. TREM2/DAP12 complex promotes proliferation and invasion of glioma cells via the PI3K-AKT signaling pathway. Folia Neuropathologica. 2025. doi:10.5114/fn.2025.156003
BibTeX
@article{Deng2025,
author = {Deng, Zhitong and Zhong, Xingming and Cai, Yong and Yang, Jianguo and Wang, Yiqi and Fei, Zhenhai and Gu, Hua and Yang, Tao and Zhao, Zhaohui},
title = {TREM2/DAP12 complex promotes proliferation and invasion of glioma cells via the PI3K-AKT signaling pathway},
journal = {Folia Neuropathologica},
year = {2025},
doi = {10.5114/fn.2025.156003}
}
EUVIMED